Obagi Medical Products Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Obagi Medical Products Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014318
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Obagi Medical Products Inc (Obagi), a subsidiary of Valeant Pharmaceuticals International Inc is a drug company that manufactures, sells, and markets skin care systems. The company provides products that include targeted solutions, tretinoin products, transformation systems, skin recovery, in-office procedures, essential products, and others. It also offers obagi professional-c serums, obagi condition and enhance systems, obagi nu-derm system, obagi blue peel, obagi blue peel radiance, and obagi rosaclear system, obagi elastiderm eye products, and others. The company’s products are used for treating fine lines, wrinkles, acne, melasma, laxity, skin shallowness, photo damage, hyper pigmentation, and others. Obagi is headquartered in Irvine, California, the US.

Obagi Medical Products Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Obagi Medical Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Obagi Medical Products Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Obagi Medical Products Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Obagi Medical Products Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Obagi Medical Products Inc, Medical Devices Deals, 2011 to YTD 2017 9
Obagi Medical Products Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Obagi Medical Products Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Obagi Medical Products Enters into Distribution Agreement with Nextcell Medical 11
Licensing Agreements 12
Sirona Biochem Enters Into Licensing Agreement With Obagi Medical For TFC-849 12
Acquisition 13
Haitong International Zhonghua Finance Acquires Obagi Medical Products from Valeant Pharma for USD190 Million 13
Valeant Pharma International Completes Acquisition Of Obagi Medical Products For US$418 Million 14
Obagi Medical Products Inc – Key Competitors 16
Obagi Medical Products Inc – Key Employees 17
Obagi Medical Products Inc – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Obagi Medical Products Inc, Pharmaceuticals & Healthcare, Key Facts 2
Obagi Medical Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Obagi Medical Products Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Obagi Medical Products Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Obagi Medical Products Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Obagi Medical Products Inc, Medical Devices Deals, 2011 to YTD 2017 9
Obagi Medical Products Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Obagi Medical Products Enters into Distribution Agreement with Nextcell Medical 11
Sirona Biochem Enters Into Licensing Agreement With Obagi Medical For TFC-849 12
Haitong International Zhonghua Finance Acquires Obagi Medical Products from Valeant Pharma for USD190 Million 13
Valeant Pharma International Completes Acquisition Of Obagi Medical Products For US$418 Million 14
Obagi Medical Products Inc, Key Competitors 16
Obagi Medical Products Inc, Key Employees 17

★海外企業調査レポート[Obagi Medical Products Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vexim SA (ALVXM):企業の財務・戦略的SWOT分析
    Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures. The company provides solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controll …
  • AMAG Pharmaceuticals Inc (AMAG)-医療機器分野:企業M&A・提携分析
    Summary AMAG Pharmaceuticals Inc (AMAG) is a biopharmaceutical company that develops and commercializes specialty pharmaceutical products. The company focuses on maternal health, anemia management and cancer supportive care. Its major products include Makena (hydroxyprogesterone caproate injection) …
  • Nevro Corp (NVRO):企業の財務・戦略的SWOT分析
    Nevro Corp (NVRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • KUKA AG (KU2):企業の財務・戦略的SWOT分析
    KUKA AG (KU2) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Bta Bank Jsc
    Bta Bank Jsc - Strategy, SWOT and Corporate Finance Report Summary Bta Bank Jsc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Oberoi Realty Limited:企業の戦略・SWOT・財務情報
    Oberoi Realty Limited - Strategy, SWOT and Corporate Finance Report Summary Oberoi Realty Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Richter Gedeon Nyrt (RICHTER):製薬・医療:M&Aディール及び事業提携情報
    Summary Richter Gedeon Nyrt (Richter) is a pharmaceutical company that develops, manufactures and commercializes a wide range of drugs including original, generic and licensed products and over-the-counter (OTC) medicines. The company’s product portfolio encompasses medicines to treat gynaecological …
  • Business Connexion Group Limited:企業の戦略的SWOT分析
    Business Connexion Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Tata Communications Limited:企業の戦略・SWOT・財務分析
    Tata Communications Limited - Strategy, SWOT and Corporate Finance Report Summary Tata Communications Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Oragenics Inc (OGEN):製薬・医療:M&Aディール及び事業提携情報
    Summary Oragenics Inc (Oragenics) focuses on the development and commercialization of novel antibiotics against infectious disease that includes treatments for oral mucositis, healthcare associated infections, obesity and dental disorders. The company develops its product candidates based on various …
  • Heritage Provider Network Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Heritage Provider Network Inc (HPN) is a managed care organization that offers medical care services. The organization operates through medical care group, urgent care centers and affiliated health plans. It offers patient care services such as urgent care, pharmacy, lab, radiology, pediatri …
  • Orbit Garant Drilling Inc.:企業の戦略・SWOT・財務情報
    Orbit Garant Drilling Inc. - Strategy, SWOT and Corporate Finance Report Summary Orbit Garant Drilling Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Panoramic Universal Limited:企業の戦略・SWOT・財務分析
    Panoramic Universal Limited - Strategy, SWOT and Corporate Finance Report Summary Panoramic Universal Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • China Suntien Green Energy Co Ltd (956):企業の財務・戦略的SWOT分析
    China Suntien Green Energy Co Ltd (956) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Southern Research Institute-製薬・医療分野:企業M&A・提携分析
    Summary Southern Research Institute (Southern Research) is a contract research organization which conducts research in the areas of advanced engineering, preclinical drug development, drug discovery and environmental protection. Its life science services include preclinical drug development, basic r …
  • ProQR Therapeutics NV (PRQR):企業の財務・戦略的SWOT分析
    Summary ProQR Therapeutics NV (ProQR) is a clinical-stage biotech company that discovers and develops drugs for the treatment of genetic disorders. The company’s lead product candidate includes QR-010, a RNA-based oligonucleotide used for the treatment of cystic fibrosis; QR-110, an oligonucleotide …
  • South Carolina Electric & Gas Company:電力:M&Aディール及び事業提携情報
    Summary South Carolina Electric & Gas Company (SCE&G), a subsidiary of Scana Corporation, is an energy utility that generates, transmits, distributes and trades of electricity; and purchases, transports and sells natural gas. The company generates electricity through diverse energy sources such as n …
  • Gard P & I (Bermuda) Ltd.:企業の戦略・SWOT・財務分析
    Gard P & I (Bermuda) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Gard P & I (Bermuda) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Biocartis Group NV (BCART):企業の製品パイプライン分析
    Summary Biocartis Group NV (Biocartis) operates as a molecular diagnostics company that provides personalized medicine for patients through its molecular diagnostics. The company undertakes the development of diagnostics technology platforms for multiplexed detection of bio-analytes, with oncology a …
  • Genera Biosystems Ltd (GBI):企業の財務・戦略的SWOT分析
    Summary Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆